David R Karp Selected Research

Vitamin D

1/2017

Combined role of vitamin D status and CYP24A1 in the transition to systemic lupus erythematosus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David R Karp Research Topics

Disease

12	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 09/2005
5	Autoimmune Diseases (Autoimmune Disease) 03/2022 - 02/2010
4	Communicable Diseases (Infectious Diseases) 01/2022 - 10/2013
3	Venous Thrombosis (Deep-Vein Thrombosis) 03/2022 - 09/2018
3	Rheumatoid Arthritis 11/2020 - 03/2011
2	Thrombosis (Thrombus) 03/2022 - 09/2018
2	Lupus Nephritis 01/2021 - 09/2005
2	Infections 01/2021 - 02/2010
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 12/2020 - 09/2018
1	Asthma (Bronchial Asthma) 01/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Eczema 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Muscular Diseases (Myopathy) 01/2020
1	Myocarditis (Carditis) 01/2020
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2020
1	Rheumatic Diseases (Rheumatism) 01/2020
1	Hypertension (High Blood Pressure) 09/2018
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2017
1	Vitamin D Deficiency 01/2017
1	Fatigue 08/2015
1	Virus Diseases (Viral Diseases) 10/2013
1	Neoplasms (Cancer) 10/2013
1	Dyslipidemias (Dyslipidemia) 10/2013
1	Diabetes Mellitus 10/2013
1	Chronic Disease (Chronic Diseases) 10/2013
1	Inflammation (Inflammations) 01/2013
1	Celiac Disease (Celiac Sprue) 03/2011
1	Systemic Scleroderma (Systemic Sclerosis) 02/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2005
1	Hypersensitivity (Allergy) 05/2003
1	Pneumococcal Infections 12/2002

Drug/Important Bio-Agent (IBA)

7	AutoantibodiesIBA 01/2022 - 09/2005
5	AntibodiesIBA 12/2020 - 01/2014
3	Antiphospholipid AntibodiesIBA 03/2022 - 09/2018
3	Immunoglobulin G (IgG)IBA 01/2021 - 12/2002
3	Proteins (Proteins, Gene)FDA Link 11/2020 - 02/2010
2	Complement System Proteins (Complement)IBA 01/2020 - 09/2005
2	AutoantigensIBA 01/2014 - 03/2011
2	Nucleic AcidsIBA 01/2014 - 01/2013
1	Cell-Free Nucleic AcidsIBA 03/2022
1	Histones (Histone)IBA 03/2022
1	serum P-component (CIt)IBA 03/2022
1	CytokinesIBA 01/2021
1	Rituximab (Mabthera)FDA Link 01/2021
1	belimumabIBA 01/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021
1	Immunoglobulin M (IgM)IBA 12/2020
1	durvalumabIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	B7-H1 AntigenIBA 01/2020
1	CTLA-4 AntigenIBA 01/2020
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 09/2018
1	Vitamin D3 24-HydroxylaseIBA 01/2017
1	hydroxide ionIBA 01/2017
1	Vitamin D FDA LinkGeneric 01/2017
1	Prostaglandins AIBA 08/2015
1	AntioxidantsIBA 08/2015
1	Fish OilsIBA 08/2015
1	NADPH Oxidases (NAD(P)H oxidase)IBA 03/2014
1	Carrier Proteins (Binding Protein)IBA 01/2014
1	Biomarkers (Surrogate Marker)IBA 01/2014
1	Therapeutic UsesIBA 10/2013
1	Pharmaceutical PreparationsIBA 10/2013
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2013
1	Biological ProductsIBA 03/2011
1	cyclic citrullinated peptideIBA 03/2011
1	Interferon Type IIBA 03/2011
1	HLA-DRB1 Chains (HLA DRB1)IBA 02/2010
1	HLA Antigens (Human Leukocyte Antigens)IBA 02/2010
1	Peptides (Polypeptides)IBA 02/2010
1	Amino Acids FDA Link 02/2010
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 11/2005
1	C-Reactive ProteinIBA 11/2005
1	MetalsIBA 05/2003
1	Complement Receptors (Complement Receptor)IBA 12/2002

Therapy/Procedure

4	Therapeutics 01/2020 - 10/2013
3	Critical Care (Surgical Intensive Care) 01/2022 - 11/2020